View Cart  

Global Recall System May be Part of U.S. FDA International Pivot

SEATTLE — The U.S. Food and Drug Administration’s (FDA) Office of International Programs (OIP) is exploring development of a single, global recall system that would encompass all domestic and international recalls.

To View This Article:


Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00